curist hemorrhoid fissure relief

Generic: lidocaine

Labeler: little pharma, inc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name curist hemorrhoid fissure relief
Generic Name lidocaine
Labeler little pharma, inc
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

glycerin 14.4 g/100g, lidocaine 5 g/100g, petrolatum 15 g/100g, phenylephrine hydrochloride .25 g/100g

Manufacturer
Little Pharma, Inc

Identifiers & Regulatory

Product NDC 72559-037
Product ID 72559-037_2fb02b00-acdc-5184-e063-6294a90ae1c8
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M015
Listing Expiration 2026-12-31
Marketing Start 2025-05-01

Pharmacologic Class

Established (EPC)
non-standardized chemical allergen [epc] amide local anesthetic [epc] antiarrhythmic [epc]
Chemical Structure
allergens [cs] glycerol [cs] amides [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe] increased igg production [pe] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72559037
Hyphenated Format 72559-037

Supplemental Identifiers

RxCUI
2642220
UPC
0372559037081
UNII
PDC6A3C0OX 98PI200987 4T6H12BN9U 04JA59TNSJ
NUI
N0000185370 N0000175629 N0000184306 N0000185001 M0000728 M0009417 N0000175682 M0000897 N0000175426 N0000175976

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name curist hemorrhoid fissure relief (source: ndc)
Generic Name lidocaine (source: ndc)
Application Number M015 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 14.4 g/100g
  • 5 g/100g
  • 15 g/100g
  • .25 g/100g
source: ndc
Packaging
  • 170 g in 1 TUBE (72559-037-08)
source: ndc

Packages (1)

Ingredients (4)

glycerin (14.4 g/100g) lidocaine (5 g/100g) petrolatum (15 g/100g) phenylephrine hydrochloride (.25 g/100g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "2fb02b00-acdc-5184-e063-6294a90ae1c8", "openfda": {"nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417", "N0000175682", "M0000897", "N0000175426", "N0000175976"], "upc": ["0372559037081"], "unii": ["PDC6A3C0OX", "98PI200987", "4T6H12BN9U", "04JA59TNSJ"], "rxcui": ["2642220"], "spl_set_id": ["2fb02b00-acdb-5184-e063-6294a90ae1c8"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]", "Amides [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]", "Local Anesthesia [PE]"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]", "Amide Local Anesthetic [EPC]", "Antiarrhythmic [EPC]"], "manufacturer_name": ["Little Pharma, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "170 g in 1 TUBE (72559-037-08)", "package_ndc": "72559-037-08", "marketing_start_date": "20250501"}], "brand_name": "Curist Hemorrhoid Fissure Relief", "product_id": "72559-037_2fb02b00-acdc-5184-e063-6294a90ae1c8", "dosage_form": "CREAM", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Allergens [CS]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Cell-mediated Immunity [PE]", "Glycerol [CS]", "Increased Histamine Release [PE]", "Increased IgG Production [PE]", "Local Anesthesia [PE]", "Non-Standardized Chemical Allergen [EPC]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "72559-037", "generic_name": "Lidocaine", "labeler_name": "Little Pharma, Inc", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Curist Hemorrhoid Fissure Relief", "active_ingredients": [{"name": "GLYCERIN", "strength": "14.4 g/100g"}, {"name": "LIDOCAINE", "strength": "5 g/100g"}, {"name": "PETROLATUM", "strength": "15 g/100g"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": ".25 g/100g"}], "application_number": "M015", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20250501", "listing_expiration_date": "20261231"}